The National Institutes of Health and the Defense Advanced Research Projects Agency will each invest as much as $70 million over five years on a chip to test compounds for toxicity before they are administered to humans. The agencies will also coordinate with the U.S. Food and Drug Administration, which could utilize the chip to accelerate the drug-approval process. "If things are going to fail, you want them to fail early," said NIH Director Francis Collins. "Now you'll be able to find out much quicker if something isn't going to work."
Published in Brief: